Ota, Kristie T
Liu, Rong-Jian
Voleti, Bhavya
Maldonado-Aviles, Jaime G
Duric, Vanja
Iwata, Masaaki
Dutheil, Sophie
Duman, Catharine
Boikess, Steve
Lewis, David A
Stockmeier, Craig A
DiLeone, Ralph J
Rex, Christopher
Aghajanian, George K
Duman, Ronald S
Article History
Received: 23 December 2013
Accepted: 27 February 2014
First Online: 13 April 2014
Competing interests
: D.A.L. currently receives investigator-initiated research support from Bristol-Myers Squibb and Pfizer and from 2012–2014 served as a consultant in the areas of target identification and validation and new compound development to Autifony, Bristol-Myers Squibb, Concert Pharmaceuticals and Sunovion.